Is Ovarian Decline Associated with Clinical Disability in Female MS Patients?
February 19th 2016Prior research has shown women suffering from multiple sclerosis (MS) often have a more benign initial course than male patients. However, these same female patients tend to quickly transition to secondary progressive disease as their approach menopause.
Read More
Potential New Therapy for Patients with Relapsing Multiple Sclerosis
February 18th 2016Results from the RADIANCE phase 2 trial of ozanimod, an investigational selective S1P 1 and 5 receptor modulators for relapsing multiple sclerosis (MS) patients showed significant reductions in the cumulative number of total gadolinium-enhancing (GdE) lesions.
Read More
Game-changing Dermatology Treatment for Hidradenitis Suppurativa Patients
February 15th 2016“Hidradenitis suppurativa (HS) is a nightmare, probably the most negatively life-impacting disease we see in all of dermatology. We finally have a therapy to address it, “ remarked Jeffrey Sobell, assistant professor of dermatology, Tufts University School of Medicine, Boston, MA, at the Skin Disease Education Foundation (SDEF) Hawaii Dermatology Seminar.
Read More
Q&A: Common Misconceptions About Psoriatic Arthritis
February 8th 2016Psoriatic arthritis, a chronic skin condition that affects patients on physically and mentally – often impacts patients’ mobility in their daily lives. Healthcare professionals across all specialties have experience when dealing with these patients in different capacities.
Read More